Written answers
Tuesday, 6 December 2016
Department of Health
Medicinal Products Prices
Louise O'Reilly (Dublin Fingal, Sinn Fein)
Link to this: Individually | In context | Oireachtas source
347. To ask the Minister for Health the number of drugs where, following the NCPE, National Centre for Pharmacoeconomics, assessment of the manufacturer's economic dossier on the cost effectiveness of a drug (details supplied), the NCPE found a drug not to be cost effective; if this information will be provided for each of the past five years with a breakdown of whether additional price reductions were successfully negotiated and agreed upon; and if he will make a statement on the matter. [38604/16]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for the administration of the community drug schemes; therefore, the matter has been referred to the HSE for attention and direct reply.
No comments